MJardin Group Announces Medical Cannabis Research Investment in Spain

New Cannabis Ventures
By NCV NewswireDec 18, 2018, 8:26 am293 pts
Collaboration with Salamanca University and the Institute of Neuroscience of Castilla y León to Study the Benefits of Cannabinoids on Epilepsy and Schizophrenia DENVER–(BUSINESS WIRE)–MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced its first medical…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Canada’s cannabis legalization initiative: Funding, outcomes, and departmental spending 72

How a woman-led biotech firm is advancing cannabis medicine 52

Alberta wholesaled nearly $700 million worth of cannabis in the 2024-2025 fiscal year 52

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.